mounjaro.com 2/ Tirzepatide is a DOUBLE THREAT #twincretin through its dual GLP-1 and GIP actions
Older options in the same class include liraglutide (Saxenda), although this is less commonly prescribed than the newer weekly injections
On Thursday, October 16, Nancy and I will participate in the 3rd Annual Municipal Health Insurance Summit hosted by BCBS MA
Effect of copper(II) on the aerobic oxidative uptake of iron(II) by horse spleen apoferritin
GLP-1 Drugs on the Rise The Food and Drug Administration (FDA) has approved a new class of GLP-1 drugs, such as Wegovy, for treating obesity specifically, regardless of a patients history with or without type 2 diabetes
(2017) demonstrated sustained ADHD symptom reduction over 12 to 13 hours in a laboratory classroom setting, with effect sizes that remained consistent from morning through early evening [1]